[Therapeutic experience in acute infantile leukosis]

17q12 microduplications: a challenge for clinicians.

American journal of medical genetics. Part A·2015

GH therapy in transition age: state of the art and future perspectives.

Minerva endocrinologica·2015

Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA.

Journal of endocrinological investigation·2014

Administering 25-hydroxyvitamin D3 in vitamin D-deficient young type 1A diabetic patients reduces reactivity against islet autoantigens.

Clinical nutrition (Edinburgh, Scotland)·2014

C-type natriuretic peptide plasma levels are reduced in obese adolescents.

Peptides·2013

Diet and physical activity "defeated" Tuberil® in treatment of childhood obesity.

Minerva endocrinologica·2013

Developmental and behavioral profile in a domestic adoptees sample: a new challenge for the pediatrician.

Minerva pediatrica·2020

A new approach to the diagnosis of short stature.

Minerva pediatrica·2020

Kounis Syndrome: a pediatric perspective.

Minerva pediatrica·2020

Human inborn errors of immunity caused by defects of receptor and proteins of cellular membrane.

Minerva pediatrica·2020

Tall stature in children and adolescents.

Minerva pediatrica·2020

Precocious puberty.

Minerva pediatrica·2020

Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.

British journal of haematology·2026

Passive Transfer of Hepatitis B Core Antibody Following Intravenous Ig Administration: Clinical Implications and Considerations.

ACR open rheumatology·2026

Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.

BMC neurology·2026

iPSC-derived neurospheres: A cellular platform for Tau and Alzheimer's disease immunotherapy.

Advances in immunology·2026

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

Lancet (London, England)·2026

Expanding the therapeutic landscape of Still's disease: the emerging role of JAK inhibitors.

Expert opinion on pharmacotherapy·2026

Related Experiment Videos

[Therapeutic experience in acute infantile leukosis]

Related Concept Videos

17q12 microduplications: a challenge for clinicians.

GH therapy in transition age: state of the art and future perspectives.

Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA.

Administering 25-hydroxyvitamin D3 in vitamin D-deficient young type 1A diabetic patients reduces reactivity against islet autoantigens.

C-type natriuretic peptide plasma levels are reduced in obese adolescents.

Diet and physical activity "defeated" Tuberil® in treatment of childhood obesity.

Developmental and behavioral profile in a domestic adoptees sample: a new challenge for the pediatrician.

A new approach to the diagnosis of short stature.

Kounis Syndrome: a pediatric perspective.

Human inborn errors of immunity caused by defects of receptor and proteins of cellular membrane.

Tall stature in children and adolescents.

Precocious puberty.

Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.

Passive Transfer of Hepatitis B Core Antibody Following Intravenous Ig Administration: Clinical Implications and Considerations.

Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.

iPSC-derived neurospheres: A cellular platform for Tau and Alzheimer's disease immunotherapy.

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

Expanding the therapeutic landscape of Still's disease: the emerging role of JAK inhibitors.

Related Experiment Videos

[Therapeutic experience in acute infantile leukosis]

Related Concept Videos

Related Articles